Metabolic approaches: GLP-1 Incretins (semaglutide): appetite suppression | GLP-1/GIP incretins (tirzepatide): dual hormonal agonism | 5-Amino-1MQ: NNMT enzyme inhibition a non-hormonal mechanism, directly targeting lipid and NAD+ metabolism
It is important to note that DSIP remains largely investigational, and formal clinical guidelines for its use have not yet been established
In addition, the transcriptomic study revealed the activation of abscisic acid, auxin, jasmonic acid biosynthesis and signaling genes during GSH treatment (Cheng et al
In the world of regenerative medicine and biohacking, BPC-157 peptide is gaining rapid popularity for its incredible healing and recovery benefits
Regulatory note: The FDA added injectable GHK-Cu to a high-risk compounded substance list in September 2023
Q: Can BPC 157 be used alongside other treatments